Filing Flows

Filing Flows › Prokidney (PROK) › Q2 2026 › vs Q2 2025

Prokidney (PROK) Q2 2026 vs Q2 2025 (year over year)

Prokidney's revenue fell $71K (-32%) from $221K in Q2 2025 to $150K in Q2 2026.

Prokidney, Q2 2026: revenue $150K (-32% year over year), net loss $46.4M, operating cash flow −$40.4M. The chart draws each line against Q2 2025, the increases inside each band.

Prokidney: what changed, Q2 2026 vs Q2 2025Prokidney: what changed, Q2 2026 vs Q2 2025Research & development$10.2MNet loss$9.5MNet loss absorbed$9.5MCash used in operations$9.0MOperating costs$8.6MOperating cash sources$8.2MCosts & expenses$7.7MOther income, net−$1.7MGeneral & admin−$1.6MWorking capital & other−$1.2M

Every line

LineQ2 2026Q2 2025Change%
Revenue$150K$221K−$71K-32%
Other income, net$1.9M$3.6M−$1.7M-46%
Net loss$46.4M$37.0M$9.5M+26%
Costs & expenses$48.5M$40.8M$7.7M+19%
Operating costs$48.5M$39.9M$8.6M+22%
Research & development$36.1M$25.9M$10.2M+39%
General & admin$12.4M$14.0M−$1.6M-12%
Operating cash sources$47.6M$39.4M$8.2M+21%
Depreciation & amortization$1.7M$1.5M$213K+15%
Share-based compensation$5.6M$6.5M−$947K-14%
Cash used in operations$40.4M$31.4M$9.0M+29%
Net loss absorbed$46.4M$37.0M$9.5M+26%
Working capital & other$1.2M$2.5M−$1.2M-51%

Questions

How much did Prokidney's revenue grow year over year in Q2 2026?

Prokidney's revenue fell $71K (-32%) from $221K in Q2 2025 to $150K in Q2 2026.

Q2 2026 results → · Compare in the interactive Sankey →